Searched for
CETUXIMAB
Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MDAlkem Laboratories, a top-seller of antibiotics, is focusing on the chronic therapy segments and is investing heavily in biosimilars and co...- Lupin Partners Enzene to roll out biosimilar Cetuximab hereIn July 2009, the US Food and Drug Administration (USFDA) approved Eli Lilly and Merck's cetuximab (Erbitux) for treatment of metastatic co...
- Lupin launches biosimilar cetuximab in pact with EnzeneCetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancer
- Reliance Lifesciences launches world's first biosimilar used to treat advanced cancersIn 2014, Reliance had entered into a similar arrangement with Torrent Pharma to sell copies of three drugs -- rituximab, adalimumab and cet...
- How Dr Reddy’s is rebooting its biosimilars playDr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.
Load More